Hafnium Oxide Nanostructure-Integrated Silk Fibroin Microneedles Reshape Cutaneous Melanocyte Microenvironment for Vitiligo Therapy

The study explores the use of hafnium oxide nanostructure-integrated silk fibroin microneedles to improve the treatment of vitiligo by reshaping the cutaneous melanocyte microenvironment. The innovative microneedles aim to enhance the delivery and efficacy of therapeutic agents directly to the skin, potentially offering a more effective treatment option for vitiligo patients. The research highlights the potential of combining advanced materials with biomedical applications to address skin pigmentation disorders.